"U.S. Food and Drug Administration staffers are recommending new warnings about psychiatric events observed in some patients taking Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, according to documents released on Friday."
Saturday, November 24, 2007
FDA staff urge psych warnings for two flu drugs
From the makers of the weight loss drugs Xenical/Orlistat/Alli:
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment